Skip to content
Open access

When Clinical and Metabolomics Data Work Together: A Comparative Framework for Multimodal Disease Classification across Machine and Deep Learning

Aug 2026 · ACS Measurement Science Au · 0 citations · 30 references

TL;DR

A modality-aware comparative framework that enables direct, side-by-side evaluation of clinical-only, metabolomics-only, and combined modeling strategies within a unified pipeline, and reveals that the dominant contributing modality shifted by scenario, reflecting differences in disease context.

Abstract

Disease classification using clinical and metabolomics data increasingly relies on multimodal integration, yet the complementary and comparative contributions of these modalities remain poorly understood. Most existing frameworks prioritize predictive performance without systematically examining how data modalities and modeling paradigms influence classification outcomes. Consequently, the relative value of individual modalities versus their integration, particularly in terms of model behavior, robustness, and interpretability, remains poorly characterized across machine learning (ML) and deep learning (DL) approaches. Here, we present a modality-aware comparative framework that enables direct, side-by-side evaluation of clinical-only, metabolomics-only, and combined modeling strategies within a unified pipeline. Unlike existing tools designed primarily for multiomics integration, this framework explicitly assesses when and how each modality contributes value across diverse classification scenarios. It supports the efficient use of available data while enabling a systematic comparison of model performance, stability, and interpretability across ML and DL methods. Rather than introducing a new classifier model, this work delivers a unified benchmarking workflow for evidence-based decision-making of modeling strategies in small-sample clinical metabolomics settings. Applied to two glomerulonephritis cohorts representing clinically-driven and metabolomics-driven classification settings, the framework revealed that the dominant contributing modality shifted by scenario, reflecting differences in disease context. These scenarios reflect realistic situations where discriminative signals arise from clinical variables, metabolic alterations, or their combination, as well as more complex cases involving subclass discrimination with overlapping profiles. While several models achieved comparable predictive accuracy, they differed in feature ranking stability, sampling sensitivity, and tendency to overfitting. Overall, this framework facilitates transparent, evidence-based selection of modeling strategies and data modalities suited to data complexity, sample size, and research objectives. Source code is available at https://github.com/kwanjeeraw/MMFramework.

Read PDF

Similar papers

Review Open access Aug 2026

From data silos to integrated diagnosis: multimodal machine learning in glioblastoma

Recent advances and emerging translational evidence for clinically oriented MML in glioblastoma is summarized, with particular emphasis on MRI-centered systems that integrate imaging with pathology, selected molecular measurements, and longitudinal clinical context.

Amin Zadeh-Shirazi, Bryan W. Day, Hui K. Gan et al. · 0 citations
Open access Aug 2026

A generalized supervised contrastive learning framework for integrative multi-omics prediction models

MB-SupCon-cont improves prediction accuracy by incorporating a generalized contrastive loss function that defines similarity and dissimilarity for continuous responses using three distance-based weighting methods, and provides superior representation learning and improves data visualization in lower-dimensional spaces.

Sen Yang, Shidan Wang, Yiqing Wang et al. · 0 citations
Review Open access Aug 2026

Multi‐omics–driven precision medicine

The value of MODPM lies not in stacking additional data layers but in building a multiscale, continuously learnable framework to link biological heterogeneity to clinically interpretable and actionable decisions.

Hui-Bo Li, Zhe Zhao, Yi-Fan Zhang et al. · 0 citations
Open access Aug 2026

Mass univariate aggregation methods for machine learning in neuroscience

Machine learning is a ubiquitous part of the modern neuroimaging toolkit, particularly for research aimed towards precision medicine goals of improving individual-level diagnosis and treatment. However, the high dimensionality of neuroimaging data poses significant challenges for constructing interpretable predictive m...

Fatemeh Doshvargar, Fabricio Cravo, Hallee Shearer et al. · 0 citations
Review Open access Aug 2026

Machine Learning–Integrated Metabolomics for Precision Pharmacotherapy: Advances, Challenges, and Clinical Translation

This review provides an overview of commonly applied ML methodologies in metabolomics-based pharmacological studies, including supervised models (Random Forest, Extreme Gradient Boosting, Support Vector Machine, Logistic Regression), unsupervised models (K-Means Clustering, Principal Component Analysis), and deep learn...

Pan Li, Jing Mao, Xiang-Lin Hu et al. · 0 citations
Open access Aug 2026

A heterogeneous multimodal ensemble framework for multi-omics breast cancer prognosis

It is demonstrated that assigning complementary roles to stacking multimodal information integration and bagging for prediction stabilization provides an effective and robust framework for multi-omics breast cancer prognosis, supporting the use of complementary ensemble paradigms for multimodal prediction in precision...

Reza Bozorgpour, Mohammadreza Soltany Sadrabadi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.